Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation for Patients with AML and FLT-3 Mutations.

Michael Schleuning, MD, Dirk Judith, Mansoor Heshmat, MD, Irina Burlakova, Zuzanna Jedlickova, MD, Elisabeth Salm, MD, Herrad Baurmann, MD, Rainer Schwerdtfeger, MD

Blood (2010) 116 (21): 4573.

https://doi.org/10.1182/blood.V116.21.4573.4573

Published: 2010

Journal Articles

Long Term Follow-up of Patients Treated with mTOR Inhibitors for Severe Chronic Gvhd Following Allogeneic Stem Cell Transplantation.

Michael Schleuning, Dirk Judith, Irena Burlakova, Zuzanna Jedlickova, Mansour Heshmat, Herrad Baurmann, Rainer Schwerdtfeger

Blood (2009) 114 (22): 2254.

https://doi.org/10.1182/blood.V114.22.2254.2254

Published: 2009

Journal Articles

Clinical Effects of Two Different Antithymocyte Globulins as Part of the Conditioning for Unrelated Stem Cell Transplantation.

Herrad Baurmann, MD, Gregor Hoppe, Karin Davis, Dirk Judith, Michael Schleuning, PhD, Rainer Schwerdtfeger, PhD

Blood (2006) 108 (11): 5317.

https://doi.org/10.1182/blood.V108.11.5317.5317

Published: 2006

Journal Articles

Allogeneic-SCT in Patients with Hematological Malignancies Aged 60 Years or Older: Importance of HLA-Matching.

Michael Schleuning, Dirk Judith, Joerg Kaltenhaeuser, Herrad Baurmann, Rainer Schwerdtfeger, PD

Blood (2005) 106 (11): 5360.

https://doi.org/10.1182/blood.V106.11.5360.5360

Published: 2005

Journal Articles

Comparison of Two Different Rabbit-ATG Preparations on the Outcome after Unrelated Stem Cell Transplants for Chronic Phase CML.

Michael Schleuning, Joerg Kaltenhaeuser, Mazur Heshmat, Irena Burlakova, Dirk Judith, Herrat Baurmann, Rainer Schwerdtfeger

Blood (2004) 104 (11): 2768.

https://doi.org/10.1182/blood.V104.11.2768.2768

Published: 2004

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis with Myeloid Metaplasia (MMM) - Transplantation Should Be Performed before Transfusion Dependence Occurs.

Herrad Baurmann, MD, Irina Burlakowa, MD, Joerg Kaltenhaeuser, MD, Dirk Judith, MD, Mansoor Heshmat, MD, Frauke Collenbusch, MD, Roland Conradi, MD, Michael Schleuning, MD, PhD, Rainer Schwerdtfeger, MD, PhD

Blood (2004) 104 (11): 1513.

https://doi.org/10.1182/blood.V104.11.1513.1513

Published: 2004

NARROW

Allogeneic Stem Cell Transplantation for Patients with AML and FLT-3 Mutations.

Long Term Follow-up of Patients Treated with mTOR Inhibitors for Severe Chronic Gvhd Following Allogeneic Stem Cell Transplantation.

Clinical Effects of Two Different Antithymocyte Globulins as Part of the Conditioning for Unrelated Stem Cell Transplantation.

Allogeneic-SCT in Patients with Hematological Malignancies Aged 60 Years or Older: Importance of HLA-Matching.

Comparison of Two Different Rabbit-ATG Preparations on the Outcome after Unrelated Stem Cell Transplants for Chronic Phase CML.

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis with Myeloid Metaplasia (MMM) - Transplantation Should Be Performed before Transfusion Dependence Occurs.

Email alerts

ASH Publications

American Society of Hematology

Allogeneic Stem Cell Transplantation for Patients with AML and FLT-3 Mutations.

Long Term Follow-up of Patients Treated with mTOR Inhibitors for Severe Chronic Gvhd Following Allogeneic Stem Cell Transplantation.

Clinical Effects of Two Different Antithymocyte Globulins as Part of the Conditioning for Unrelated Stem Cell Transplantation.

Allogeneic-SCT in Patients with Hematological Malignancies Aged 60 Years or Older: Importance of HLA-Matching.

Comparison of Two Different Rabbit-ATG Preparations on the Outcome after Unrelated Stem Cell Transplants for Chronic Phase CML.

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis with Myeloid Metaplasia (MMM) - Transplantation Should Be Performed before Transfusion Dependence Occurs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only